148 related articles for article (PubMed ID: 10981232)
1. [Population screening for cervical cancer; eventual gain not expected to increase by testing for papillomavirus].
Giard RW; Coebergh JW
Ned Tijdschr Geneeskd; 2000 Aug; 144(35):1664-8. PubMed ID: 10981232
[TBL] [Abstract][Full Text] [Related]
2. HPV testing in cervical screening.
Cuzick J
Pharmacoepidemiol Drug Saf; 2001; 10(1):33-6. PubMed ID: 11417064
[No Abstract] [Full Text] [Related]
3. [Test for human papillomavirus: no added value by inclusion in improved population screening for cervical cancer at this point].
Hanselaar AG
Ned Tijdschr Geneeskd; 2000 Aug; 144(35):1668-71. PubMed ID: 10981233
[TBL] [Abstract][Full Text] [Related]
4. [Human papillomavirus and screening for cervical cancer: state of art and prospects].
Meijer CJ; Rozendaal L; Voorhorst FJ; Verheijen R; Helmerhorst TJ; Walboomers JM
Ned Tijdschr Geneeskd; 2000 Aug; 144(35):1675-9. PubMed ID: 10981235
[TBL] [Abstract][Full Text] [Related]
5. Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?
Vink MA; Bogaards JA; Meijer CJ; Berkhof J
Int J Cancer; 2015 Jul; 137(2):420-7. PubMed ID: 25484263
[TBL] [Abstract][Full Text] [Related]
6. Persistent HPV infection and cervical cancer risk: is the scientific rationale for changing the screening paradigm enough?
Franco EL
J Natl Cancer Inst; 2010 Oct; 102(19):1451-3. PubMed ID: 20841606
[No Abstract] [Full Text] [Related]
7. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
Ronco G; Segnan N; Giorgi-Rossi P; Zappa M; Casadei GP; Carozzi F; Dalla Palma P; Del Mistro A; Folicaldi S; Gillio-Tos A; Nardo G; Naldoni C; Schincaglia P; Zorzi M; Confortini M; Cuzick J;
J Natl Cancer Inst; 2006 Jun; 98(11):765-74. PubMed ID: 16757701
[TBL] [Abstract][Full Text] [Related]
8. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
9. HPV primary screening for cervical cancer: more pain than protection.
Davey DD; Armenti CA
Diagn Cytopathol; 2000 Jun; 22(6):333-5. PubMed ID: 10820524
[No Abstract] [Full Text] [Related]
10. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
[TBL] [Abstract][Full Text] [Related]
11. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.
Berkhof J; de Bruijne MC; Zielinski GD; Bulkmans NW; Rozendaal L; Snijders PJ; Verheijen RH; Meijer CJ
Int J Cancer; 2006 Apr; 118(7):1759-68. PubMed ID: 16217759
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
[TBL] [Abstract][Full Text] [Related]
14. Time to consider HPV testing in cervical screening.
Cuzick J
Ann Oncol; 2001 Nov; 12(11):1511-4. PubMed ID: 11822748
[No Abstract] [Full Text] [Related]
15. HPV testing in cervical screening.
Brink AA; Snijders PJ; Meijer CJ; Berkhof J; Verheijen RH
Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):253-66. PubMed ID: 16359926
[TBL] [Abstract][Full Text] [Related]
16. Can papilloma virus testing be used to improve cervical cancer screening?
Jenkins D; Sherlaw-Johnson C; Gallivan S
Int J Cancer; 1996 Mar; 65(6):768-73. PubMed ID: 8631589
[TBL] [Abstract][Full Text] [Related]
17. A new generation of studies of human papillomavirus DNA testing in cervical cancer screening.
Franco EL
J Natl Cancer Inst; 2009 Dec; 101(23):1600-1. PubMed ID: 19903806
[No Abstract] [Full Text] [Related]
18. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
[TBL] [Abstract][Full Text] [Related]
19. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
[TBL] [Abstract][Full Text] [Related]
20. HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.
Rijkaart DC; Berkhof J; van Kemenade FJ; Coupe VM; Rozendaal L; Heideman DA; Verheijen RH; Bulk S; Verweij W; Snijders PJ; Meijer CJ
Br J Cancer; 2012 Feb; 106(5):975-81. PubMed ID: 22251922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
